STOCK TITAN

Petros Pharmaceuticals to Present at the Access to Giving Virtual Investor Conference on July 14, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NEW YORK, July 12, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 – 15, 2021.

Mr. Boctor will deliver his corporate presentation on July 14 at 3:30pm ET.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com.

Investors can register here. 

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.

 

Cision View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-14-2021-301331250.html

SOURCE Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

NASDAQ:PTPI

PTPI Rankings

PTPI Latest News

PTPI Stock Data

3.77M
6.20M
11.8%
1.7%
2.13%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NEW YORK

About PTPI

at petros, we are bringing new approaches to the most challenging conditions in men's health. we seek to understand the various health phases throughout a man’s journey. we collaborate with researchers, scientists, medical thought leaders and payers to ensure our therapies aid in restoring men’s body function to vitality.